Return to homepagePandemic Pact

Immunity to SARS-CoV-2 in the population: Study of the presence of antibodies to SARS-CoV-2

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $320,000

  • Funder

    Lundbeck Foundation

  • Principal Investigator

    Professor Karen Angeliki Krogfelt

  • Research Location

    Denmark

  • Lead Research Institution

    Roskilde University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

How quickly does the Danish population develop immunity to coronavirus, and at which stage of the pandemic is Denmark? This will be investigated in a project headed by Professor Karen Angeliki Krogfelt, Roskilde University. Researchers will look for antibodies to COVID-19 in blood samples sent to the Danish National Biobank from all types of patient admitted during the epidemic to Danish hospitals for disorders other than COVID-19.